Vaccination against senile dementia has become a reality

Science is closer to developing a shot that can stop dementia. This vaccine has demonstrated high safety among laboratory mice.

Researchers from the University of Texas are working on a vaccine for Alzheimer’s disease, which suspends the concentrations of both species of toxic proteins in the brain. They affect the development of the characteristic symptoms of dementia. The basis of the injection are DNA protein of Alzheimer’s disease, which can train the immune system to fight with these components and not allow them to accumulate in the brain. This vaccine is not the first attempt to slow down the development of dementia, but now the vaccine can be administered through the skin, and, as shown by observations, does not cause dangerous swelling of the brain, the same as other vaccinations.

Note that we are not talking about a cure against dementia, which remains incurable, and the means of prevention or vaccination. After the injection the likelihood of developing dementia can be reduced significantly. At least the data of inoculation reduced the number of cases of Alzheimer’s disease in laboratory mice half. These are very good results, and in the near future scientists expect with this prick, strengthen the immune system against the protein clusters and platelets, to achieve a significant breakthrough in the fight against senile dementia.

In the US, the diagnosis of Alzheimer’s disease is every 65 seconds. It is expected that the number of patients will increase three times by 2050. Science still can’t figure out what causes dementia and how to deal with it. (READ MORE)